Advancements in HER2-Directed Therapies Abound for HER2+ Metastatic Breast Cancer

1 year ago 47

Aditya Bardia, MD, MPH, FASCO, discusses the evolving role of T-DXd for patients with HER2-positive advanced breast cancer.

1. Homepage
2. Breast Cancer
3. Advancements in HER2-Directed Therapies Abound for HER2+ Metastatic Breast Cancer